Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (201-210 of 227) with videos related to

Pageof 23
Sort By:
The Journal of Infectious Diseases|April 3, 2025
Bacterial and viral co-infections in adult patients hospitalized with COVID-19 throughout the pandemic: A Multinational Cohort Study in the EuCARE ProjectPontus Hedberg, Karol Serwin, Maria Francesca Greco, et al.
Antiviral Therapy|September 13, 2006
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysisMassimo Puoti, Alessandro Cozzi-Lepri, Giuseppe Paraninfo, et al.
Plos One|February 23, 2021
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infectionCristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, et al.
AIDS Research and Therapy|August 6, 2022
Observational cohort study of rilpivirine (RPV) utilization in EuropeAlessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, et al.
Viruses|February 28, 2023
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort StudyCristina Mussini, Alessandro Cozzi-Lepri, Marianna Meschiari, et al.
The Lancet Regional Health. Europe|March 13, 2024
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE projectPontus Hedberg, Milosz Parczewski, Karol Serwin, et al.
Viruses|September 28, 2024
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 StudyFrancesca Bai, Andrea Santoro, Pontus Hedberg, et al.
Open Forum Infectious Diseases|July 17, 2024
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North AmericaJulie Ambia, Suzanne M Ingle, Kathleen McGinnis, et al.
Lancet (London, England)|July 20, 2010
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study, Rebecca K Lodwick, Caroline A Sabin, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2014
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencingAlessandro Cozzi-Lepri, Marc Noguera-Julian, Francesca Di Giallonardo, et al.
Pageof 23

Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
The Journal of Infectious Diseases|April 3, 2025
Bacterial and viral co-infections in adult patients hospitalized with COVID-19 throughout the pandemic: A Multinational Cohort Study in the EuCARE ProjectPontus Hedberg, Karol Serwin, Maria Francesca Greco, et al.
Antiviral Therapy|September 13, 2006
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysisMassimo Puoti, Alessandro Cozzi-Lepri, Giuseppe Paraninfo, et al.
Plos One|February 23, 2021
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infectionCristina Mussini, Alessandro Cozzi-Lepri, Marianna Menozzi, et al.
AIDS Research and Therapy|August 6, 2022
Observational cohort study of rilpivirine (RPV) utilization in EuropeAlessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, et al.
Viruses|February 28, 2023
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort StudyCristina Mussini, Alessandro Cozzi-Lepri, Marianna Meschiari, et al.
The Lancet Regional Health. Europe|March 13, 2024
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE projectPontus Hedberg, Milosz Parczewski, Karol Serwin, et al.
Viruses|September 28, 2024
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 StudyFrancesca Bai, Andrea Santoro, Pontus Hedberg, et al.
Open Forum Infectious Diseases|July 17, 2024
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North AmericaJulie Ambia, Suzanne M Ingle, Kathleen McGinnis, et al.
Lancet (London, England)|July 20, 2010
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study, Rebecca K Lodwick, Caroline A Sabin, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2014
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencingAlessandro Cozzi-Lepri, Marc Noguera-Julian, Francesca Di Giallonardo, et al.
Pageof 23